High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.


This study assessed the long-term use of fluvastatin, alone or in combination with bezafibrate, in patients with severe familial hypercholesterolemia who, in a previous study, did not achieve target levels (European Atherosclerosis Society) of low density lipoprotein cholesterol (LDL-C) with fluvastatin at 60 mg/day plus bezafibrate 200 mg/day, with or… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.